When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACHV - Achieve Life Sciences launches mid-stage study of cytisinicline for smoking cessation; shares up 28% premarket
Achieve Life Sciences Inc.
Nano cap Achieve Life Sciences (NASDAQ:ACHV) is up 28% premarket on above-average volume in response to its launch of a Phase 2 clinical trial, ORCA-1, evaluating cytisinicline (cytisine) for smoking cessation.
More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move,